174 related articles for article (PubMed ID: 9641194)
1. Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephritis associated with Castleman's disease.
Furuichi K; Wada T; Shimizu M; Segawa C; Ohta S; Takasawa K; Kobayashi K; Yokoyama H
Nephrol Dial Transplant; 1998 Jun; 13(6):1556-8. PubMed ID: 9641194
[No Abstract] [Full Text] [Related]
2. A Case of Dual Positive Glomerulonephritis With Plasma Cell Dyscrasia.
Yamada T; Miyashita H; Rasheed M; Chung M; LiLi ; Salem FE; Campbell KN
Am J Med; 2020 Aug; 133(8):e436-e437. PubMed ID: 32081655
[No Abstract] [Full Text] [Related]
3. Fibrillary glomerulonephritis in Castleman's disease.
Miadonna A; Salmaso C; Palazzi P; Elli A; Braidotti P; Lambertenghi Deliliers G
Leuk Lymphoma; 1998 Jan; 28(3-4):429-35. PubMed ID: 9517516
[TBL] [Abstract][Full Text] [Related]
4. Membranous glomerulonephritis associated with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Zhou GY
Nefrologia; 2012 Jul; 32(4):548-51. PubMed ID: 22806300
[No Abstract] [Full Text] [Related]
5. Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.
Yorioka N; Taniguchi Y; Amimoto D; Miyata H; Yamakido M; Taguchi T
Am J Nephrol; 1999; 19(4):527-9. PubMed ID: 10460948
[TBL] [Abstract][Full Text] [Related]
6. Castleman's disease with Kaposi's sarcoma and glomerulonephritis.
Chim CS; Lam KY; Chan KW
Am J Med; 1999 Aug; 107(2):186-8. PubMed ID: 10460057
[No Abstract] [Full Text] [Related]
7. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
[TBL] [Abstract][Full Text] [Related]
8. Chronic bronchiectasis and anti-myeloperoxidase antibody related rapidly progressive necrotizing glomerulonephritis.
Pai P; Rustom R; Bone JM; Bell GM
Clin Nephrol; 1998 Apr; 49(4):262-4. PubMed ID: 9582559
[TBL] [Abstract][Full Text] [Related]
9. [Case of systemic Castleman's disease with hypothyroidism].
Okubo R; Yoshida T; Kimura T; Okuma K; Morioka E; Kuno S; Tamura K; Suzumiya A; Tsuboi Y
Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1321-3. PubMed ID: 10465981
[No Abstract] [Full Text] [Related]
10. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.
Souid M; Terki NH; Nochy D; Hillion D
Clin Nephrol; 2001 Apr; 55(4):337-8. PubMed ID: 11334325
[No Abstract] [Full Text] [Related]
12. Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane and anti-myeloperoxidase antibody.
Cheng CY; Chen TH; Sue YM; Lee WS
J Microbiol Immunol Infect; 2019 Jun; 52(3):498-500. PubMed ID: 28709840
[No Abstract] [Full Text] [Related]
13. ANCA-positive rapidly progressive glomerulonephritis: there may be more to the diagnosis than you think!
Messiaen T; Lefebvre C; Zech F; Cosyns JP; Jadoul M
Nephrol Dial Transplant; 1997 Apr; 12(4):839-41. PubMed ID: 9141032
[No Abstract] [Full Text] [Related]
14. Experience on antineutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.
Rollino C; Roccatello D; Coppo R; Menegatti E; Basolo B; Giraudo G; Martina G; Piccoli G
Contrib Nephrol; 1991; 94():101-6. PubMed ID: 1687269
[No Abstract] [Full Text] [Related]
15. Antineutrophil cytoplasmic antibody-associated necrotizing glomerulonephritis: Not always pauci-immune.
Lim CC; Teo S; Choo JC
Nephrology (Carlton); 2013 Aug; 18(8):579. PubMed ID: 23865543
[No Abstract] [Full Text] [Related]
16. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
[No Abstract] [Full Text] [Related]
17. Dynamics of D-serine reflected the recovery course of a patient with rapidly progressive glomerulonephritis.
Hesaka A; Yasuda K; Sakai S; Yonishi H; Namba-Hamano T; Takahashi A; Mizui M; Hamase K; Matsui R; Mita M; Horio M; Isaka Y; Kimura T
CEN Case Rep; 2019 Nov; 8(4):297-300. PubMed ID: 31359345
[TBL] [Abstract][Full Text] [Related]
18. Elastase-ANCA-associated idiopathic necrotizing crescentic glomerulonephritis--a report of three cases.
Seidowsky A; Hoffmann M; Ruben-Duval S; Mesbah R; Masy E; Kyndt X; Maouad B; Billion S; Noël LH; Vanhille P; Bataille P
Nephrol Dial Transplant; 2007 Jul; 22(7):2068-71. PubMed ID: 17478493
[No Abstract] [Full Text] [Related]
19. Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease).
Chan TM; Cheng IK; Wong KL; Chan KW
Nephron; 1993; 65(4):628-32. PubMed ID: 8302422
[TBL] [Abstract][Full Text] [Related]
20. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
Bienaimé F; Clerbaux G; Plaisier E; Mougenot B; Ronco P; Rougier JP
Am J Kidney Dis; 2007 Nov; 50(5):821-5. PubMed ID: 17954295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
